Pin-Ji Lei

13PUBLICATIONS
68CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityHumoural immunology and immunochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 08, 2026
Targeting Tumor-derived Sphingosine Kinase 2 Unleashes Antitumor Immunity and Improves Survival of Mice with Group 3 Medulloblastoma.

|Feb 19, 2026
Collagen-Bearing Exosomes from Breast Cancer-Associated Fibroblasts Promote T-cell Dysfunction.

Samir Jana, Matthew Lawton, Pin-Ji Lei

|Dec 30, 2025
Overcoming impaired antigen presentation in tumor-draining lymph nodes facilitates immunotherapy.

Meghan J O'Melia, Lutz Menzel, Pin-Ji Lei

|Dec 08, 2025
Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma.

Xin Liu, Zelong Liu, Chengzhan Zhu

|Oct 03, 2025
The anti-virus T cell response dominates the anti-cancer response in oncolytic virus therapy.

Meghan J O'Melia, Kailan Sierra-Davidson, Miranda A Robert

|Sep 26, 2025
Overcoming impaired antigen presentation in tumor draining lymph nodes facilitates immunotherapy.

Meghan J O'Melia, Lutz Menzel, Pin-Ji Lei

Pageof 3

Frequent Collaborators

5 joint publications

Timothy P Padera

5 joint publications

Dan G Duda

4 joint publications

Hengbo Zhou

4 joint publications

Meghan J O'Melia